May 09,2024

Woebot Health Wins MedTech Breakthrough's Mental Health Innovation Award

Woebot Health has received the "Mental Health Innovation Award" in the 8th annual MedTech Breakthrough Awards. This recognition highlights their Woebot Health Platform, which utilizes clinically proven techniques and artificial intelligence to provide accessible chat-based mental health support. The platform includes Woebot, a digital companion offering personalized support through chat-based conversations based on evidence-based approaches like Cognitive Behavioral Therapy, Interpersonal Psychotherapy, and Dialectical Behavioral Therapy. The CEO of Woebot Health, Michael Evers, expressed excitement about the award and emphasized the importance of innovative digital solutions in improving mental health care.

PRODUCT

#cbt

#chatbot

View Analyst & Ambassador Comments
Go to original news
Sep 12,2023

PayrollPlans Announces Pioneering Partnership with Woebot Health and Curai Health to Provide Virtual Mental Health and Primary Care Solutions to Underserved Workers

PayrollPlans, Woebot Health, and Curai Health unveil a partnership to deliver a virtual benefit solution with AI-driven primary care and mental health services to over 2 million Small-to-Medium Enterprises employing over 70 million underserved American workers. PayrollPlans is a proprietary digital ecosystem that integrates into payroll software used by Independent Payroll Processors and their Small-to-Medium Enterprise clients. Through this partnership, Woebot Health and Curai Health enable employers to provide their employees with enhanced access to unlimited and affordable mental health and primary care services, a core tenet of the PayrollPlans mission. Woebot Health will deliver its AI-powered mental health tool Woebot for Adults, an accessible, reliable, and scalable mental health ally. When coupled with Curai Health’s AI-enabled virtual clinic, their specially trained clinicians will provide convenient virtual primary care, improved health outcomes, and reduced costs. 

COLLABORATION PARTNERSHIP

#institution

#virtual care

#chatbot

View Analyst & Ambassador Comments
Go to original news
Jan 02,2024 TOP STORY

Fitterfly launches JEDi: A Leap Forward in AI-enabled Diabetes Interventions in India

Introducing JEDi — the new empathetic conversational coaching AI developed by the X-labs Innovation team at Fitterfly. JEDi aims to provide users with reliable and empathetic assistance in managing their nutrition, fitness, and overall well-being in a structured 28-day regimen, built as a game. It analyses user responses, health data, and preferences to offer customised advice and nudges towards healthier habits. "The JEDi architecture is hybrid with rule-based NLP on an Expert system foundation complemented with large language models (LLMs). It's connected to the Fitterfly knowledge base which powers our therapies," said Ammar Jagirdar, Head - X Labs at Fitterfly. JEDi is now available for use on the Fitterfly Metabolic Health app. The modules of JEDi will also be available as plug and play solutions for corporates to support employee wellness. It will offer seamless integration with healthcare systems, provide data-driven insights with better outcomes empowering patient self management and cost-efficient healthcare with an aim to help reduce the diabetes burden of India.

PRODUCT

#coaching

#chatbot

View Analyst & Ambassador Comments
Go to original news
Oct 26,2023 TOP STORY

First Randomized Controlled Trial Comparing Woebot to Clinician-Led Psychotherapy Reveals Digital Mental Health Intervention is Non-Inferior in Reducing Depressive Symptoms Among Teens

Woebot Health announced positive results from a study at Children’s Hospital of The King’s Daughters (CHKD) showing that the digital mental health intervention W-GenZD, a Woebot-based study app, led to reductions in depressive symptoms that were non-inferior to those achieved by a clinician-led telehealth Cognitive Behavioral Therapy (CBT) skills group. The study was designed to investigate the feasibility, satisfaction and non-inferiority (for PHQ-8) of W-GenZD (n = 71) compared to a group receiving CBT skills delivered via telehealth and led by a licensed mental health clinician (n = 70). Participants in both the W-GenZD and telehealth groups reported a significant reduction in depressive symptoms (PHQ-8) from baseline to end of treatment (week 4) and had similar levels of intervention feasibility and satisfaction. The results were presented in a poster presentation at the American Academy of Child and Adolescent Psychiatry (AACAP) conference.

CLINICAL STUDY

#mobile app

#chatbot

View Analyst & Ambassador Comments
Go to original news
Oct 18,2023 TOP STORY

Virtua Health Signs With Woebot Health To Deliver Adjunctive Mental Health Tool To Patients

Virtua Health and Woebot Health today announced a collaboration that allows Virtua Health primary care clinicians and specialists to provide Woebot for Adults as a clinically directed adjunctive tool for people waiting to see a behavioral health provider or seeking support outside of traditional in-person therapy sessions. As part of the collaboration, the Virtua Health team will work with Woebot Health to implement a shared resource center providing the training, deployment and reporting resources to seamlessly deliver Woebot for Adults within the organization’s clinical care pathway. The collaboration will also add to the industry’s understanding of the benefits of digital therapeutics by assessing aggregate patient outcomes, healthcare resource utilization and health economics results. The organizations are kicking off their collaboration in advance of the typically stress-filled holiday season, and expect to expand it in the future. Financial terms were not disclosed.

COLLABORATION PARTNERSHIP

#institution

#mobile app

#chatbot

View Analyst & Ambassador Comments
Go to original news
Aug 28,2023

New Woebot Health Study Highlights AI's Ability to Address Equity and Accessibility Gaps in Mental Health Care

Woebot Health today announced the results from a new study of Woebot for Adults (previously Woebot-LIFE), a digital mental health intervention that provides in-the-moment support to people experiencing symptoms of anxiety and depression. The study, in which 256 adults received an 8-week intervention, was designed to assess changes in depression and anxiety symptoms, stress, resilience, burnout, levels of engagement and therapeutic working alliance, as well as access and barriers to care. Key study findings showed that participants with baseline clinical levels of depressive or anxiety symptoms experienced significant declines in self-reported symptoms. Woebot for Adults is a non-prescription medical device under FDA enforcement discretion; it is not evaluated, cleared or approved by FDA. Robinson added the study will periodically relaunch to collect new data and new insights as part of the company’s “Science in the Loop” approach to product development.

CLINICAL STUDY

#chatbot

#mobile app

View Analyst & Ambassador Comments
Go to original news
Aug 25,2023

ChatGPT Shows Limited Ability to Recommend Guidelines-Based Cancer Treatments

With ChatGPT now at patients’ fingertips, researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, assessed how consistently the artificial intelligence chatbot provides recommendations for cancer treatment that align with National Comprehensive Cancer Network (NCCN) guidelines. Their findings, published in JAMA Oncology, show that in approximately one-third of cases, ChatGPT 3.5 provided an inappropriate (“non-concordant”) recommendation, highlighting the need for awareness of the technology’s limitations.

CLINICAL STUDY

#chatbot

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jul 28,2022

Integrated Healthcare Executive: Improving mental health management with chatbots

Monique Levy, chief commercial & strategy officer, Woebot Health, reviews how the pandemic impacted mental health and how consumers prefer to engage with technology for their care.

#chatbot

View Analyst & Ambassador Comments
Go to original news
Feb 10,2023

AI is our path to holistic mental health care

Accroding to the Founder and the President of Woebot Health, Alison Darcy, AI will not replace human therapists but can complement their work by providing better self-directed tools. She mentions that Cognitive Behavioral Therapy (CBT) is mentioned as a model that translates well into a digital setting and can be supported by AI, and suggests that AI can enhance engagement, gather data, and dynamically learn to improve treatment approaches.

#chatbot

View Analyst & Ambassador Comments
Go to original news
Jun 06,2017

Your Facebook Messenger AI therapist will see you now

The interview discusses Woebot, an AI-based virtual therapist available on Facebook Messenger. Dr. Alison Darcy, the creator of Woebot, explains that its conversational style is designed to make users feel comfortable discussing their mental health. Woebot engages users in conversation to address common fears around therapy and offers support for various mental health concerns. It is built to meet users where they are and provides resources for crisis situations. Clinical research showed that Woebot significantly reduced symptoms of depression and anxiety over a two-week period. Woebot offers tiered pricing for its services and employs a combination of decision trees, keyword triggers, Natural Language Processing (NLP), and machine learning to provide effective interactions.

#chatbot

#cbt

View Analyst & Ambassador Comments
Go to original news
Subscribe to CHATBOT